Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126690831 | 12669083 | 1 | I | 20160804 | 20160819 | 20160819 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-121341 | RANBAXY | 59.00 | YR | M | Y | 0.00000 | 20160819 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126690831 | 12669083 | 1 | PS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | N | UNK | 89247 | ||||||||
| 126690831 | 12669083 | 2 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | UNK | N | U | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126690831 | 12669083 | 1 | Focal segmental glomerulosclerosis |
| 126690831 | 12669083 | 2 | Focal segmental glomerulosclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126690831 | 12669083 | DE |
| 126690831 | 12669083 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126690831 | 12669083 | Cellulitis | |
| 126690831 | 12669083 | Cryptococcal cutaneous infection | |
| 126690831 | 12669083 | Disseminated cryptococcosis | |
| 126690831 | 12669083 | Pulmonary embolism | |
| 126690831 | 12669083 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |